Garfield Alastair bought RYTM
February 14, 2025 · Form 4 insider transaction
Garfield Alastair bought 40,000 shares of Rhythm Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderGarfield Alastair
Role—
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 14, 2025
Filing dateFebruary 19, 2025
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options vest and become exercisable, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date, as to 6.25% of the total number of shares of common stock subject to the options upon the Reporting Person's completion of each successive three months of service to the Issuer after February 14, 2025, such that the option shall be fully vested and exercisable on February 14, 2029.